Analyte measured to Lymecycline bioequivalence study [Bioanalytics]

posted by Mauricio Sampaio  – Brazil, 2013-09-02 17:50 (4285 d 10:56 ago) – Posting: # 11409
Views: 9,069

Dear,

in Public Assessment Report of Lymecycline 408 capsules from MHRA (UK/H/1889/002/DC)* the pharmacokinetics results of bioequivalence study of Lymecycline is based on data from Tetracycline and not Lymecycline (page 13). However, in page 10, the Lymecycline is described as active substance.

In this case Lymecycline is a prodrug and serves as a type of precursor to the intended drug (Tetracycline)?

Please, clarify my doubt.

* http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con205367.pdf

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,674 registered users;
60 visitors (0 registered, 60 guests [including 10 identified bots]).
Forum time: 04:46 CEST (Europe/Vienna)

Every man gets a narrower and narrower field of knowledge
in which he must be an expert in order to compete with other people.
The specialist knows more and more about less and less
and finally knows everything about nothing.    Konrad Lorenz

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5